http://orcid.org/0000-0002-8146-0580
Figures
Abstract
Advances in the field of metagenomics using culture-independent methods of microbial identification have allowed characterization of rich and diverse communities of bacteria in the lungs of healthy humans, mice, dogs, sheep and pigs. These data challenge the long held belief that the lungs are sterile and microbial colonization is synonymous with pathology. Studies in humans and animals demonstrate differences in the composition of airway microbiota in health versus disease suggesting respiratory dysbiosis occurs. Using 16S rRNA amplicon sequencing of DNA extracted from rectal and oropharyngeal (OP) swabs, bronchoalveolar lavage fluid (BALF), and blood, our objective was to characterize the fecal, OP, blood, and lower airway microbiota over time in healthy cats. This work in healthy cats, a species in which a respiratory microbiota has not yet been characterized, sets the stage for future studies in feline asthma in which cats serve as a comparative and translational model for humans. Fecal, OP and BALF samples were collected from six healthy research cats at day 0, week 2, and week 10; blood was collected at week 10. DNA was extracted, amplified via PCR, and sequenced using the Illumina MiSeq platform. Representative operational taxonomic units (OTUs) were identified and microbial richness and diversity were assessed. Principal component analysis (PCA) was used to visualize relatedness of samples and PERMANOVA was used to test for significant differences in microbial community composition. Fecal and OP swabs provided abundant DNA yielding a mean±SEM of 65,653±6,145 and 20,6323±4,360 sequences per sample, respectively while BALF and blood samples had lower coverage (1,489±430 and 269±18 sequences per sample, respectively). Oropharyngeal and fecal swabs were significantly richer than BALF (mean number OTUs 93, 88 and 36, respectively; p < 0.001) with no significant difference (p = 0.180) in richness between time points. PCA revealed site-specific microbial communities in the feces, and upper and lower airways. In comparison, blood had an apparent compositional similarity with BALF with regard to a few dominant taxa, but shared more OTUs with feces. Samples clustered more by time than by individual, with OP swabs having subjectively greater variation than other samples. In summary, healthy cats have a rich and distinct lower airway microbiome with dynamic bacterial populations. The microbiome is likely to be altered by factors such as age, environmental influences, and disease states. Further data are necessary to determine how the distinct feline microbiomes from the upper and lower airways, feces and blood are established and evolve. These data are relevant for comparisons between healthy cats and cats with respiratory disease.
Citation: Vientós-Plotts AI, Ericsson AC, Rindt H, Grobman ME, Graham A, Bishop K, et al. (2017) Dynamic changes of the respiratory microbiota and its relationship to fecal and blood microbiota in healthy young cats. PLoS ONE 12(3): e0173818. https://doi.org/10.1371/journal.pone.0173818
Editor: Brenda A. Wilson, University of Illinois at Urbana-Champaign, UNITED STATES
Received: November 22, 2016; Accepted: February 27, 2017; Published: March 9, 2017
Copyright: © 2017 Vientós-Plotts et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All sequence data have been deposited in the NCBI Short Read Archive (SRA) under the accession number [SRA: PRJNA350163].
Funding: The author (s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: BALF, bronchoalveolar lavage fluid; OP, Oropharyngeal; OTU, operational taxonomic unit; PCA, principal component analysis
Introduction
The Human Microbiome Project provided a platform for the study of site-specific microbial communities by using DNA-based sequencing to characterize resident bacterial populations. The gastrointestinal microbiota has been the most studied site thus far, and these studies continue to provide evidence of the influence that these complex microbial communities have on host health and disease. Early studies of site-specific microbial communities did not include the respiratory tract, due to the belief that the human lungs were sterile, and that organisms isolated from the lower airways were indicative of disease or bacterial translocation from the upper airways. With the help of culture-independent techniques, it has been demonstrated that healthy human airways harbor complex microbial populations, sometimes referred to as the “core airway microbiota” [1]. Alterations in these microbial communities have been documented in a variety of inflammatory airway diseases in humans, including asthma, COPD [2, 3], and cystic fibrosis [4]. However, it is not clear what role these microbial communities may play in host health, and prevention or exacerbation of disease.
Most of the research pertaining to the airway microbiota has been conducted in humans, and knowledge about the composition of the airway microbiota in companion animals that share our environment is limited. Inflammatory airway disease is common in dogs and cats, in particular chronic bronchitis in both species and allergic asthma in cats. Recently, it was shown that healthy dogs have a rich and complex lower airway microbiota that is distinct from other sites including the upper airways and gastrointestinal tract [5]. These data in healthy dogs are critical for an understanding of the role of microbial communities in infectious and non-infectious inflammatory canine respiratory diseases. Cats have been proposed to be a comparative and translational model for allergic airway disease as both experimentally induced and spontaneous feline asthma share similar features to human allergic asthma [6, 7]. In humans, differences in the microbial composition between healthy and asthmatic airways have been reported [8–10]. To date, studies documenting the presence of and characterizing the healthy airway microbiota have not been published in cats.
The primary aim of this study was to document the presence of and characterize the respiratory microbiota in healthy cats. As a secondary objective, fecal and blood samples were also collected and analyzed to investigate possible correlations between the microbial communities found at each site. As it is speculated that the airway microbiome may be established as a result of microbial migration via microaspiration, inhalation of bacteria and direct mucosal dispersion[11], comparing the upper and lower airways and the fecal microbiota provide evidence that although there is overlap between the populations, each site is distinct. Like the lungs, until recently, the blood had also considered a sterile environment, however, it has also been shown to possess a microbiome[12]. In addition, it has been speculated that the blood microbiome may be a link between intestinal dysbiosis and other conditions like diabetes[13], cardiovascular diseases[14], liver fibrosis[15], and other inflammatory diseases[16]. By including the blood samples, we were able to characterize the circulating microbial DNA present in healthy cats, which may provide pilot data for future studies evaluating potential correlations between the blood and respiratory microbiomes in health and disease, in both human and veterinary patients.
Materials and methods
Ethics statement
All studies were performed in accordance with the Guide for the Use and Care of Laboratory Animals, and were approved by the University of Missouri Institutional Animal Care and Use Committee (MU IACUC protocol #7891).
Cats
Cats were bred from a colony (Comparative Internal Medicine Laboratory, University of Missouri, Columbia MO), were all sexually intact and were aged < 1 year (25–35 weeks by end of study). Cats belonged to one of two litters: litter A consisted of 3 females and litter B consisted of 2 males and 1 female. At the start of the study, cats in litters A and B were 24, and 14 weeks old respectively. Cats were group housed by sex with 2 males and 4 females housed in separate, large runs with elevated platforms to climb, hanging hammocks, and a variety of enrichment toys. Cats were socialized by members of the research team. The average (± standard deviation) body weight was 3.0 ± 1.3 kg. Cats were transitioned to a commercial dry diet formulated for growth (Purina growth formula, St. Louis, MO) at 4 weeks old, and remained on this diet for the duration of the study. Access to food and clean drinking water were provided ad libitum. Prior to anesthesia for sample collection, cats were fasted for at least 12 hours to minimize the likelihood of aspiration. Cats were determined to be healthy by absence of respiratory clinical signs, a normal physical examination by a board-certified veterinary internal medicine specialist and lack of cytologic evidence of infection or inflammation from bronchoalveolar lavage fluid (BALF) samples. Euthanasia was not an endpoint of the study; all cats were subsequently adopted into private homes.
Sample collection
Fecal swabs, oropharyngeal (OP) swabs, and BALF were collected at the beginning of the study (day 0), and at week 2, and week 10. Additionally, blood was collected on week 10. The cats were anesthetized with ketamine 4 mg/kg IV. After anesthetic induction but prior to intubation, a sterile cotton tip swab was inserted at a minimum of 4 cm rectally to obtain a fecal sample, while avoiding contact with the perianal area. A second moistened sterile swab was used to vigorously rub the caudodorsal aspect of the oropharynx with the mouth manually opened and tongue pulled forward, while avoiding contact with the oral cavity. The oropharyngeal and rectal swabs were each added to 5 mL of sterile saline and placed on ice for transport to the laboratory. Cats were intubated using a sterile 3.5 to 4 French endotracheal tube. To collect BALF, a sterile 8 French red rubber catheter was threaded through the sterile endotracheal tube until it was gently wedged in a lower airway. A single 20 ml aliquot of sterile saline was instilled, aspirated, and placed on ice. Four milliliters of whole blood was obtained by jugular venipuncture (site shaved of fur and prepared with ethanol) into sterile tubes with the anticoagulant EDTA.
Promptly after collection, fecal, OP, BALF, and blood samples were centrifuged to pellet bacterial cells. Supernatant was discarded and pellets were resuspended in 800 μL lysis buffer adapted from Yu et al. (4% sodium dodecyl sulfate, 50 mM EDTA, 500 mM NaCl, and 50 mM Tris-HCl pH 8.0) [17]. All samples were banked at -80°C until the end of the study, and DNA was extracted as a single batch.
DNA extraction
DNA from feces, OP, and BALF was extracted using the bead beating plus column method as previously described [5]. DNA from blood was isolated from 4 mL of anti-coagulated whole blood. Cells were lysed by adding 40 mL of hypotonic ACK buffer (150 mM NH4Cl, 10 mM KHCO3, 1 mM EDTA pH 7.2) and were incubated at room temperature for 10 min. Samples were centrifuged at room temperature for 20 min at 2,500 ×g. This procedure was repeated once, the supernatant was discarded and 2 mL of lysis buffer (500 mM NaCl, 50 mM Tris-HCl, 50 mM EDTA, 4% SDS) with 0.1 mg/mL proteinase K were added. Samples were incubated at 60°C for 3 hours, followed by organic solvent extraction. After incubation with at 37°C for 30 min with 0.1 mg/mL RNase A, DNA was precipitated with ethanol, re-suspended in 0.5mL TE (10 mM Tris-HCl pH 8.2, 1 mM EDTA), samples were stored at -20°C until PCR and sequencing.
16S rRNA library preparation, sequencing and informatics
Library construction and sequencing was completed at the University of Missouri DNA Core facility as previously described [5]. Assembly, filtering, binning, and annotation of DNA sequences was performed at the MU Informatics Research Core Facility as previously reported [5] with the exception that principal component analysis of 1/4 root-transformed data was performed using Past 3.13 (www.folk.uio.no/ohammer/past/).
Statistical snalysis
Statistical analysis was performed using Sigma Plot 12.3 (Systat Software Inc., Carlsbad, CA). Differences between sample collection sites in DNA yield, coverage, richness and relative abundance were determined using repeated measures ANOVA on ranks with post hoc comparisons via Tukey test. Testing via PERMANOVA, using Past 3.13, was performed to identify differences in β-diversity between samples sites. Results were considered statistically significant for p values ≤ 0.05.
Results
Lower airways and blood represent sites of lower biomass than feces and upper airways
Fluorometric measurements employing a broad-range dsDNA kit revealed that DNA yields varied widely between the samples sites: fecal samples (mean ± SEM of 2.05 ± 0.48 ng/μL), OP swabs (0.63 ± 0.45 ng/μL), BALF (15.31 ± 3.61 ng/μL), and blood (52.06±12.27 ng/μL). Three out of 18 fecal samples and 6 out of 18 oropharyngeal samples were below the limit of detection. The samples that were below the limit of detection were not excluded from further analysis. In order to maximize the amount of loading template, all samples were concentrated to the minimum volume required for PCR.
Following amplification and sequencing, the total number of high-quality sequences detected (i.e., coverage) varied by site with fecal followed by OP samples yielding the highest number of sequences per sample (mean ± SEM of 65,653 ± 6,145 and 20,633 ± 4,360, respectively). As anticipated, BALF and blood had significantly lower coverage (1,489 ± 430 and 269 ± 18, respectively) compared to rectal and OP swabs (Fig 1).
Like letters indicate significant (p <0.05) differences.
For all samples, even those with lower biomass, and DNA yield below the limit of detection, consistent and interpretable data were obtained.
The richness of rectal and OP swabs was higher than that of BALF and blood; the mean number of operational taxonomic units (OTUs, groups of sequences sharing a minimum of 97% nucleotide identity) was 88, 93, 36 and 15, respectively (Fig 2). This was not unexpected as the lower airways and blood had lower DNA yields, which is consistent with sites with lower biomass. Dynamic changes in richness varied with site. In feces, there was no significant difference in richness between time points. In OP samples, there was significant increase in richness from week 6 to week 10 (mean OTUs 79 and 105, respectively; p = 0.012). In contrast, in BALF there was a significant decrease in richness from week 2 to week 10 (41 and 27, respectively; p = 0.043).
Like letters indicate significant (p <0.05) differences.
Proteobacteria dominates healthy feline airways
A distinct difference between microbial populations from the fecal and airway samples was detected at the taxonomic level of phylum (Fig 3). Consistent with previous reports in dogs [5] and humans [18], but in contrast to previous reports in cats [19]the predominant phyla detected in rectal swabs were Bacteroidetes (mean ± SEM relative abundance of 33.26 ± 3.11%), Firmicutes (31.55 ± 4.21%), Proteobacteria (21.70 ± 3.11%) and Fusobacteria (11.68 ± 2.40%). Proteobacteria was the most abundant phylum in the upper and lower airways (60.00 ± 3.23%, and 62.36 ± 6.72% in OP and BALF, respectively). Similar to rectal swabs, and in contrast to previous reports in humans [12] Bacteroidetes (67.60 ± 1.36%), and Proteobacteria (22.26 ± 0.56%), were the predominant phyla detected in blood samples.
From day 0 to week 10, there was a significant increase in the relative abundance of Bacteroidetes in feces (from 18.8± 4.33% to 33.05± 3.46%; p < 0.001), in OP (from 17.6±2.63% to 31.19±2.2%; p = 0.028) and in BALF (from 14.41±6.35% to 55.01±4.94%; p < 0.001). In contrast, there was a significant decrease in the relative abundance of Proteobacteria from day 0 to week 10 in OP (from 74.28±3.15% to 54.78±2.89%; p = 0.016), and in BALF (from 81.65±6.63% to 27.26±1.33%; p < 0.001). The relative abundance of the phyla Firmicutes and Fusobacteria did not significantly change over time.
Resolved to the taxonomic level of family (Fig 4), the differences in microbial composition between sites are highlighted, in particular when comparing rectal swabs with airway samples. The phylum Bacteroidetes was detected at greater relative abundance in feces, OP swabs, and blood samples relative to BALF, however it comprised different bacterial families and OTUs. In rectal swabs, the phylum Bacteroidetes consisted primarily of organisms in the Bacteroidaceae family (30.12 ± 3.60%). In OP swabs, this phylum was represented by the Porphyromonadaceae and Paraprevotellaceae families (12.45 ± 1.29% and 5.46 ± 0.87%, respectively). Although microbes in the phylum Bacteroidetes were present at much higher proportions in blood compared to BALF, the majority of the microbes in this phylum belonged to the family Sphingobacteriaceae (64.24±2.38% and 22.56±5.08% in blood and BALF, respectively).
The identity of dominant OTUs shown on the right.
Microbes in the phylum Firmicutes were represented by the families Tissierellaceae and Lachnospiraceae (10.31 ± 3.87% and 10.00 ± 1.87%, respectively), while the phylum Fusobacteria was dominated by the family Fusobacteriaceae (11.68 ± 2.40%). These families were mainly found in fecal samples and were detected at relatively low abundance in other sample sites. Proteobacteria were detected in fecal and blood samples with similar frequency; however, the DNA was annotated to different families. In rectal swabs, it was mostly represented by families Campylobacteraceae and Enterobacteriaceae (8.87 ± 3.32% and 7.09 ± 1.57%, respectively) while these taxa were rare in all other sample sites. In blood samples, Bradyrhizobiaceae (19.71 ± 2.30%) was the most abundant family in this phylum, and it was rarely found in fecal or OP samples. The airways were predominated by Proteobacteria, with Pasteurellaceae, Moraxellaceae, and Pseudomonadaceae being the most abundant families in the OP samples (15.99 ± 1.93%, 14.79 ± 1.73%, and 10.21 ± 3.69%, respectively). Pseudomonadaceae and Bradyrhizobiaceae were the most abundant families in BALF samples (34.24 ± 7.16% and 15.83 ± 2.18%, respectively). All taxa detected at greater than 0.50% mean relative abundance in at least one sample site are listed in Table 1.
Data presented as mean ± standard error of the mean (SEM).
Healthy airways have dynamic changes in relative abundance of key families within the phyla Proteobacteria and Bacteroidetes
The fecal microbiome was relatively stable over the study period. The only significant changes in the relative abundance of microbial families were increases in Paraprevotellaceae, Pseudomonadaceae, and Alcaligenaceae, none of which ever exceeded 2.5% of the total population. In OP samples, changes over time included a decrease in relative abundance of Pseudomonadaceae from day 0 to week 10 (30.57 ± 3.84% to 0.05 ± 0.01%; p < 0.001) and an increase in the relative abundance of family Moraxellaceae from day 0 to week 10 (11.15 ± 2.4% to 22.34 ± 1.80%; p = 0.008). Significant changes in the lower airway microbiota occurred between week 2 and week 10, when there was a significant decrease in the relative abundance of Pseudomonadaceae (from 52.64 ± 10% to 0.08 ± 0.01%; p = 0.005) with a concurrent increase in the relative abundance of Sphingobacteriaceae (from 7.5 ± 3.19% to 47.2 ± 5.4%; p < 0.001).
Diversity of microbial communities detected at each sample site are significantly different
Principal component analysis (PCA) was used to assess the β-diversity of the bacterial populations found at each site. When samples from all sites were included in the analysis, principal component 1 (PC1), accounting for 33.51% of the variation among the samples, showed complete separation of the fecal and OP microbial populations from BALF and blood (Fig 5). Interestingly, blood and BALF samples clustered closely together with regard to the first two principal components, reflecting the similarity seen in the stacked bar charts. Testing for differences in community structure between sample sites and time-points was performed via PERMANOVA. Two-way PERMANOVA was performed initially to determine the presence or strength of main effects due to either fixed variable; significant differences were detected associated with both sample site and date of collection (p = 0.0001; F = 32.26 and 9.62 respectively). Additionally, a significant, albeit weak, interaction was detected between variables (p = 0.0088; F = -0.23). To address those interactions and provide pairwise comparisons, a one-way PERMANOVA was performed. Considering first the differences within sample site and between time-point, the OP swabs differed most from time-point to time-point, and the fecal samples differed the least. Specifically, the OP swabs at any given time of collection differed significantly from the other two collections, with F values ranging from 2.20 to 10.58) (Table 2). Conversely, the composition of fecal samples only differed between the day 0 and week 10 samples and the strength of that difference was low (p = 0.04; F = 2.03). As predicted based on the stacked bar charts (Fig 4), the week 10 BALF samples differed significantly from the first two samples, but day 0 did not differ from week 2. Considering the differences between sample sites, significant differences were detected between all pairwise comparisons across sample sites, regardless of when the samples were collected. These data indicate that the microbial communities detected in each sample site are significantly different and that the airway communities may be more dynamic over time than the fecal microbiota. Additionally, it should be noted that while the scant DNA detected in blood samples appeared quite similar in composition to that identified in the final BALF sample, statistical analysis detected differences between these two sites. A subjective comparison of the OTUs found in at least one sample from each site provides further evidence of the relationship between the bacteria detected in the blood relative to the respiratory and fecal samples (Fig 6). Specifically, all OTUs detected in the blood were also detected in at least one fecal sample.
Unweighted principal component analysis of samples from all four sample sites (feces, BALF, OP and blood) PC1 versus PC2; legends at right. The ellipses represent 95% intervals.
Numbers in red indicate the number of OTUs from within that group that were also detected in blood.
Discussion
To the authors’ knowledge, the current data provide the first evidence of a rich and dynamic lower respiratory tract microbiota in healthy cats. Previously, standard culture techniques with isolation of low numbers of bacteria from healthy cat airways has led to speculation that in the absence of lower airway inflammation, cats harbored limited types and small numbers of microbes, likely because of aspiration of oropharyngeal secretions [20, 21]. In the current study, the gastrointestinal tract, upper airways (OP), and lower airways (BALF) each have unique microbial communities, while microbial OTUs detected in blood samples overlapped completely with those found in the gastrointestinal tract. While there was some degree of regional continuity with roughly 92% of OTUs in the BALF being present in the OP samples (Fig 6), bacterial communities as assessed by diversity indices suggested BALF and OP populations were completely separated and thus, distinct. This likely represents adaptation to unique niches.
Different regions of the body have distinct, dynamic microbial communities. Each community within the body varies in structure depending on the location [22]. The gastrointestinal tract is one of the most complex ecosystems studied, and resident organisms provide a defense mechanism against colonization with pathogenic microbes, aid in nutrient metabolism and immunomodulation. In turn, the gastrointestinal tract provides the resident organisms a stable, nutrient rich environment [23]. It is this symbiotic relationship that helps maintain homeostasis in healthy individuals [24]. Alterations in that intricate balance within the microbial community can occur secondary to multiple factors, including environmental influences, exposure to pathogenic organisms, and the use of medications including antibiotics. Aberrant alterations in relative abundance or diversity of the microbial community members, particularly those with deleterious effects on health, are referred to as dysbiosis. The changes leading to dysbiosis may vary depending on the ecosystem. For example, in the gastrointestinal tract high biodiversity is associated with health and decreases in diversity are reported in disease, whereas in the vagina the opposite is true [25, 26].
In this population of cats the predominant phyla detected in rectal swabs were Bacteroidetes (mean ± SEM relative abundance of 33.26 ± 3.11%), Firmicutes (31.55 ± 4.21%), this is in contrast to previous studies in healthy cats. In one report [27], the majority of OTUs (87.3%) pertained to the phylum Firmicutes whereas only 2.4% were in the phylum Bacteroidetes. Another study[28] reported that Firmicutes was the most abundant phylum in cats (92%) and only 0.45% of the OTUs identified belonged to the phylum Bacteroidetes. Both of these studies sampled feces from a heterogeneous population of pet cats that lived in different environments, had variety of diet and a wide age range. Therefore, this discrepancy may be due to the differences in populations, the population in this study consisted of cats in similar age range, and stable environments and diet. Another point to consider is that a study[19] that evaluated microbial diversity along the gastrointestinal tract of healthy cats identified that the majority of OTUs in the phylum Bacteroidetes were isolated from the ileum and colon (13% and 50% respectively), followed by 5% in the rectum. Therefore, the rectal swabs may be more representative of the microbiota in the colon than evacuated fecal material.
The presence and characterization of the lower airway microbiome in humans has only recently become the focus of research. Prior to the use of culture-independent techniques, microbial populations identified in the lower airways were considered to be associated with disease or contamination from the upper airways. Recent studies comparing the upper and lower airway microbiota in humans have concluded that a distinct microbiota is present at each site [29–32]. The basis of initial colonization of the airways is poorly understood, however potential sources include uterine-placental environment; the maternal birth canal; and intestinal, dermal, and other environmental organisms introduced by inhalation and microaspiration [33]. Even with low biomass, the lung microbiome can contribute to the state of health and is susceptible to derangements from external factors including systemic (e.g., antibiotics) and inhaled (e.g., cigarette smoke, pollutants, etc.) substances [31, 34].
In the respiratory tract, dysbiosis has been described in asthma, COPD, and cystic fibrosis, and has been noted in comparisons between smokers and non–smokers [10, 29, 35, 36]. Loss of beneficial microorganisms, expansion of potentially harmful or pathogenic organisms and loss of overall diversity have all been described as contributing factors to dysbiosis [37]. Characterization and understanding of changes to the core microbiome that occur in disease have led to questions regarding potential opportunities for therapeutic intervention [38]. Further studies investigating whether or not restoration of a “health-associated” microbial community could represent an alternative treatment approach in respiratory disease, are warranted.
Knowledge of a healthy airway microbiome sets the stage for identification of states of dysbiosis with feline respiratory diseases relevant to human health. Cats are the only animal species that naturally develop a condition associated with eosinophilic airway inflammation, airway hyperresponsiveness and airway remodeling similar to allergic asthma in humans [7]. Although some differences exist, humans and cats share many anatomic, physiologic and immunologic features. Environmental allergens have been implicated in both feline and human asthma. With this knowledge, a model consisting of sensitization and challenge of cats with house dust mite allergen or Bermuda grass allergen and development of an asthmatic phenotype has been used investigate human and feline asthma [39]. As humans and pet cats share their environment, pet cats are susceptible to similar diseases such as asthma, making them an excellent pre-clinical model [7].
In human adults, the most abundant phyla detected in the lower airways are Bacteroidetes (Prevotella and Porphyromonas spp.) and Firmicutes (Veillonella and Streptococus spp.); organisms belonging to the phylum Proteobacteria (Pseudomonas, Acinetobacter) were less abundant [1, 29, 31, 40, 41]. Although these taxa were identified in all feline BALF samples throughout the study period, their relative abundance at the level of phyla was significantly different. Samples from day 0 and week 2 were predominated by Proteobacteria. However, a significant decrease in this phylum with concurrent increase in Bacteroidetes was observed from week 2 to week 10. These changes may have been associated with maturation. The cats in this study were at least 6 months of age at the conclusion of the study; this is the age at which cats reach sexual maturity. Similar changes in relative abundance at the level of phyla of murine and human neonatal respiratory microbiomes have been reported [42, 43]. A longitudinal study in children suggests that there may be a transition of respiratory microbial communities toward a more adult-like composition that takes place over the first two years of life [44].
The current study was relatively small and samples were obtained over a period of 10 weeks, therefore it is possible that the airway microbiome was still changing as a function of maturation. The small sample size does not provide enough power [45] to determine the significance of the changes in microbial community composition over time. However, the aim of this study was to characterize the microbial composition, not to compare it over time. Although the frequency of performing lavage has not been associated with changes in cell numbers or types over time in cats, [46] it is still possible that repeated lavage might have influenced a change in microbial community composition over time. Additionally, environmental factors such as diet, water, air quality and housing could play a role in alterations of the bacterial composition of the airways. However, since the cats were in a controlled environment, it is less likely that these factors may have influenced the changes observed.
The presence of bacterial 16S rRNA in blood was first documented in healthy humans in 2001 [16, 47]. A recent report described that the blood microbiome in healthy adult humans was significantly different than the gastrointestinal microbiome, as it was mostly composed of taxa from the phylum Proteobacteria with minimal representation of taxa from the Bacteroidetes and Firmicutes [12]. In our study, all of the OTUs identified in the blood were also found in the fecal swabs. While the role of the blood microbiome in health and disease remains to be determined, it has been hypothesized that it may be of importance in the development of the gut-brain axis, and the gut-lung axis [48–51]. Further studies are needed to better understand if the blood microbiome may provide means for immunomodulation, diagnosis, or therapeutic interventions in systemic disease.
Conclusion
Until recently, respiratory microbiology has emphasized that bacteria cultured from the lung are pathogens and are implicated in disease. This study was the first to document the existence of a rich and diverse airway microbiota in healthy cats. Bacterial communities may be dynamic depending on the age and environment of an individual. Advances in metagenomics can help characterize a dynamic respiratory ecosystem that can be disrupted in disease, altering homeostasis between host and microbiota. A better understanding of the differences in microbial communities in healthy versus inflammatory airways sets the stage for future studies to determine if the microbiota can be modulated to attenuate disease and/or restore immunologic tolerance.
Author Contributions
- Conceptualization: ACE CRR.
- Data curation: AVP ACE.
- Formal analysis: AVP ACE CRR.
- Investigation: AVP CRR MEG AG KB LAC HR.
- Project administration: AVP CRR HR.
- Supervision: CRR.
- Visualization: AVP ACE CRR.
- Writing – original draft: AVP ACE CRR.
- Writing – review & editing: AVP ACE CRR MEG LAC HR.
References
- 1. Charlson ES, Bittinger K, Chen J, Diamond JM, Li H, Collman RG, et al. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One. 2012;7(9):e42786. PubMed Central PMCID: PMCPMC3435383. pmid:22970118
- 2. Huang YJ, Erb-Downward JR, Dickson RP, Curtis JL, Huffnagle GB, Han MK. Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions. Transl Res. 2017;179:71–83. PubMed Central PMCID: PMCPMC5164976. pmid:27392936
- 3. Park H, Shin JW, Park SG, Kim W. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PLoS One. 2014;9(10):e109710. PubMed Central PMCID: PMCPMC4199592. pmid:25329665
- 4. Hogan DA, Willger SD, Dolben EL, Hampton TH, Stanton BA, Morrison HG, et al. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease. PLoS One. 2016;11(3):e0149998. PubMed Central PMCID: PMCPMC4778801. pmid:26943329
- 5. Ericsson AC, Personett AR, Grobman ME, Rindt H, Reinero CR. Composition and Predicted Metabolic Capacity of Upper and Lower Airway Microbiota of Healthy Dogs in Relation to the Fecal Microbiota. PLoS One. 2016;11(5):e0154646. PubMed Central PMCID: PMCPMC4852910. pmid:27136381
- 6. Williams K, Roman J. Studying human respiratory disease in animals—role of induced and naturally occurring models. J Pathol. 2016;238(2):220–32. pmid:26467890
- 7. Reinero CR, DeClue AE, Rabinowitz P. Asthma in humans and cats: is there a common sensitivity to aeroallegens in shared environments? Environ Res. 2009;109(5):634–40. Epub 2009/03/14. pmid:19281975
- 8. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131(2):346–52 e1-3. PubMed Central PMCID: PMCPMC4403876.
- 9. Huang YJ, Nariya S, Harris JM, Lynch SV, Choy DF, Arron JR, et al. The airway microbiome in patients with severe asthma: Associations with disease features and severity. J Allergy Clin Immunol. 2015;136(4):874–84. Epub 2015/07/30. PubMed Central PMCID: PMCPMC4600429. pmid:26220531
- 10. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1):e8578. PubMed Central PMCID: PMCPMC2798952. pmid:20052417
- 11. Dickson RP, Huffnagle GB. The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease. PLoS Pathog. 2015;11(7):e1004923. PubMed Central PMCID: PMCPMC4497592. pmid:26158874
- 12. Paisse S, Valle C, Servant F, Courtney M, Burcelin R, Amar J, et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion. 2016;56(5):1138–47. pmid:26865079
- 13. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011;3(9):559–72. PubMed Central PMCID: PMCPMC3265717. pmid:21735552
- 14. Amar J, Lange C, Payros G, Garret C, Chabo C, Lantieri O, et al. Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One. 2013;8(1):e54461. PubMed Central PMCID: PMCPMC3555817. pmid:23372728
- 15. Lelouvier B, Servant F, Paisse S, Brunet AC, Benyahya S, Serino M, et al. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. Hepatology. 2016;64(6):2015–27. pmid:27639192
- 16. Potgieter M, Bester J, Kell DB, Pretorius E. The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev. 2015;39(4):567–91. PubMed Central PMCID: PMCPMC4487407. pmid:25940667
- 17. Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques. 2004;36(5):808–12. pmid:15152600
- 18. Mentula S, Harmoinen J, Heikkila M, Westermarck E, Rautio M, Huovinen P, et al. Comparison between cultured small-intestinal and fecal microbiotas in beagle dogs. Appl Environ Microbiol. 2005;71(8):4169–75. Epub 2005/08/09. PubMed Central PMCID: PMCPMC1183360. pmid:16085799
- 19. Ritchie LE, Steiner JM, Suchodolski JS. Assessment of microbial diversity along the feline intestinal tract using 16S rRNA gene analysis. FEMS Microbiol Ecol. 2008;66(3):590–8. pmid:19049654
- 20. Dye JA, McKiernan BC, Rozanski EA, Hoffmann WE, Losonsky JM, Homco LD, et al. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J Vet Intern Med. 1996;10(6):385–400. Epub 1996/11/01. pmid:8947872
- 21. Padrid PA, Feldman BF, Funk K, Samitz EM, Reil D, Cross CE. Cytologic, microbiologic, and biochemical analysis of bronchoalveolar lavage fluid obtained from 24 healthy cats. Am J Vet Res. 1991;52(8):1300–7. pmid:1928912
- 22. Martin R, Miquel S, Langella P, Bermudez-Humaran LG. The role of metagenomics in understanding the human microbiome in health and disease. Virulence. 2014;5(3):413–23. PubMed Central PMCID: PMCPMC3979869. pmid:24429972
- 23. Martin R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermudez-Humaran LG. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact. 2013;12:71. PubMed Central PMCID: PMCPMC3726476. pmid:23876056
- 24. Leser TD, Molbak L. Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environ Microbiol. 2009;11(9):2194–206. pmid:19737302
- 25. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55(2):205–11. PubMed Central PMCID: PMCPMC1856500. pmid:16188921
- 26. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353(18):1899–911. pmid:16267321
- 27. Ritchie LE, Burke KF, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Characterization of fecal microbiota in cats using universal 16S rRNA gene and group-specific primers for Lactobacillus and Bifidobacterium spp. Vet Microbiol. 2010;144(1–2):140–6. pmid:20092970
- 28. Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol. 2011;76(2):301–10. pmid:21261668
- 29. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011;6(2):e16384. PubMed Central PMCID: PMCPMC3043049. pmid:21364979
- 30. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A. 2012;109(34):13769–74. PubMed Central PMCID: PMCPMC3427132. pmid:22872870
- 31. Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol. 2014;14(12):827–35. pmid:25421702
- 32. Yun Y, Srinivas G, Kuenzel S, Linnenbrink M, Alnahas S, Bruce KD, et al. Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture. PLoS One. 2014;9(12):e113466. PubMed Central PMCID: PMCPMC4254600. pmid:25470730
- 33. Warner BB, Hamvas A. Lungs, microbes and the developing neonate. Neonatology. 2015;107(4):337–43. Epub 2015/06/06. PubMed Central PMCID: PMCPMC4465447. pmid:26044101
- 34. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med. 2013;187(12):1382–7. Epub 2013/04/26. pmid:23614695
- 35. Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013;7(3):245–57. Epub 2013/06/06. PubMed Central PMCID: PMCPMC4007100. pmid:23734647
- 36. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. 2012;6(2):471–4. PubMed Central PMCID: PMCPMC3260497. pmid:21796216
- 37. Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16(7):1024–33. PubMed Central PMCID: PMCPMC4143175. pmid:24798552
- 38. Smits HH, Hiemstra PS, Prazeres da Costa C, Ege M, Edwards M, Garn H, et al. Microbes and asthma: Opportunities for intervention. J Allergy Clin Immunol. 2016;137(3):690–7. Epub 2016/03/08. pmid:26947981
- 39. Norris Reinero CR, Decile KC, Berghaus RD, Williams KJ, Leutenegger CM, Walby WF, et al. An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen. Int Arch Allergy Immunol. 2004;135(2):117–31. Epub 2004/09/04. pmid:15345910
- 40. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187(10):1067–75. PubMed Central PMCID: PMCPMC3734620. pmid:23491408
- 41. Einarsson GG, Comer DM, McIlreavey L, Parkhill J, Ennis M, Tunney MM, et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016;71(9):795–803. Epub 2016/05/06. pmid:27146202
- 42. Gollwitzer ES, Saglani S, Trompette A, Yadava K, Sherburn R, McCoy KD, et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med. 2014;20(6):642–7. pmid:24813249
- 43. Lohmann P, Luna RA, Hollister EB, Devaraj S, Mistretta TA, Welty SE, et al. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia. Pediatr Res. 2014;76(3):294–301. pmid:24941215
- 44. Biesbroek G, Tsivtsivadze E, Sanders EA, Montijn R, Veenhoven RH, Keijser BJ, et al. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med. 2014;190(11):1283–92. pmid:25329446
- 45. La Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, et al. Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS One. 2012;7(12):e52078. PubMed Central PMCID: PMCPMC3527355. pmid:23284876
- 46. McCarthy GM, Quinn PJ. Age-related changes in protein concentrations in serum and respiratory tract lavage fluid obtained from cats. Am J Vet Res. 1991;52(2):254–60. pmid:1826417
- 47. Nikkari S, McLaughlin IJ, Bi W, Dodge DE, Relman DA. Does blood of healthy subjects contain bacterial ribosomal DNA? J Clin Microbiol. 2001;39(5):1956–9. PubMed Central PMCID: PMCPMC88056. pmid:11326021
- 48. Wang H, Liu JS, Peng SH, Deng XY, Zhu DM, Javidiparsijani S, et al. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol. 2013;19(40):6794–804. PubMed Central PMCID: PMCPMC3812478. pmid:24187454
- 49. Dickson RP, Cox MJ. The premature invocation of a 'gut-lung axis' may obscure the direct effects of respiratory microbiota on pneumonia susceptibility. Gut. 2016. Epub 2016/04/03.
- 50. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun. 2014;38:1–12. Epub 2013/12/29. PubMed Central PMCID: PMCPMC4062078. pmid:24370461
- 51. Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol. 2014;20(39):14105–25. Epub 2014/10/24. PubMed Central PMCID: PMCPMC4202342. pmid:25339800